<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01064583</url>
  </required_header>
  <id_info>
    <org_study_id>Flavanols-PAD</org_study_id>
    <nct_id>NCT01064583</nct_id>
  </id_info>
  <brief_title>Cocoa Flavanols and Painfree Walking Distance</brief_title>
  <official_title>Long-term Effect of Dietary Intervention With Flavanol-containing Cocoa on Vascular Function of Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To characterize potential vascular long-term effects of flavanols in patients with peripheral
      artery occlusive disease (PAOD), a placebo-controlled double-blinded randomized control study
      will be performed in 62 patients randomized in two groups. Patients will twice daily receive
      either a flavanol-poor cocoa drink or a flavanol-rich cocoa drink over a period of 60 days
      months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      62 Type 2 diabetics according to the criteria of the American Diabetes Association suffering
      from PAOD with a pain free walking distance less than 250m will be enrolled.

      Patients will twice daily receive either a flavanol-poor cocoa drink (13mg/dl)or a
      flavanol-rich cocoa drink (596mg/dl) over a period of 60 days.

      The general condition, the pain free walking distance and the vascular function measured by
      Doppler Ultrasound will be determined before and two month after cocoa ingestion
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>painfree walking distance</measure>
    <time_frame>60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>endothelial function</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Peripheral Artery Disease</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>flavanol rich cocoa drink (596mg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dissolved in water, twice daily intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>flavanol poor cocoa drink ( 13mg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dissolved in water, twice daily intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cocoa</intervention_name>
    <description>dissolved in water twice-daily intervention</description>
    <arm_group_label>flavanol rich cocoa drink (596mg)</arm_group_label>
    <arm_group_label>flavanol poor cocoa drink ( 13mg)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  peripheral artery disease (Fontaine IIb)

          -  diabetes mellitus

          -  &gt; 18 years

        Exclusion Criteria:

          -  acute and terminal renal failure

          -  acute infection

          -  heart failure (NYHA III-IV)

          -  arrhythmias
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Heiss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heinrich Heine University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Malte Kelm, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Heinrich Heine University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heinrich Heine University</name>
      <address>
        <city>Düsseldorf</city>
        <state>NRW</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uniklinik-duesseldorf.de/kardiologie</url>
  </link>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2010</study_first_submitted>
  <study_first_submitted_qc>February 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2010</study_first_posted>
  <last_update_submitted>November 12, 2013</last_update_submitted>
  <last_update_submitted_qc>November 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

